Technology ❯ Biotechnology

Genetic Testing

Data Privacy DNA Analysis Consumer Products Data Security Data Management DNA Sequencing Cell-Free DNA Consumer Genetics 23andMe Illumina Personalized Medicine Direct-to-Consumer Services User Data Management Investigative Genetic Genealogy DNA Data Gene Sequencing Consumer Technology DNA Profiling Whole Genome Sequencing Forensic Applications Machine Learning Algorithms Animal Genetics Pharmacogenetics Genealogy Databases Next-Generation Sequencing Epigenetic Tools

VolitionRx Reports >99% Tumor DNA Purity With ‘Capture-Seq’

Results remain preliminary pending peer review, with larger independent studies expected.

BillionToOne Soars in Nasdaq Debut After Upsized $273 Million IPO

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe